V.S. Sakalo
State Institution «Academician O.F.Vozianov Institute of Urology of the National Academy of Medical Sciences of Ukraine» · 53 works · 577 citations · h-index 4
Top works
- Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
- Phase 3 MAGNITUDE study: First results of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) as first-line therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination repair (HRR) gene alterations.
- Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial
- Effect of androgen suppression on bone mineral density in patients with prostate cancer.
- Radionuclide diagnosis of regional metastases in patients with testicular tumours
- OCT 3/4 staining in germ cell tumor of testis: A sensitive marker for seminoma and embryonal carcinoma and to detect TIN in paratumorous tissue
- N38 SENSITIVITY AND SPECIFICITY OF SERUM MARKER CA-125 IN PATIENTS WITH UROTHELIAL CARCINOMA
- Ukrain treatment in a patient with non-seminomatous germ-cell tumour of testis (case report).
- The Application of Nd-Yag Laser in the Surgical Treatment of Skin Cancer
- A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancer
- C119 EFFECT OF SURGICAL TREATMENT ON SURVIVAL WITHOUT RECURRENCE (RFS) IN PATIENTS WITH UROTHELIAL CARCINOMA OF UPPER URINARY TRACT (UCUUT)
- C124 CLINICAL AND MORPHOLOGICAL PECULIARITIES OF TESTICULAR TUMORS IN CHILDREN
- C47: Repeat retroperitoneal lymphadenectomy in patients with regional metastases of nonseminomatous germ cell testicular tumors
- Гистологические и иммуногистохимические параллели в прогнозе рака предстательной железы
- Простатичний специфічний антиген у прогнозуванні метастатичного ураження скелету у хворих на рак передміхурової залози
- Hypogonadism as a Risk Factor for Metabolic Syndrome and Vascular Diseases in Patients with Germ Cell Tumors of the Testis After Treatment
- [The prognostic importance of the immunohistochemical study of protein p53 in transitional-cell bladder tumors].
- Expression of CD44 and CD24 in tumor tissue from patients with prostate cancer
- [Treatment of patients with testicular neoplasms with inguinal lymph node metastasis].
- Рак передміхурової залози - проблема сучасної медицини